-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
BNT162b2 mRNA vaccine is the world's first large-scale use of the new crown pneumonia mRNA vaccines, 2020 December 20, Israel launched a nationwide vaccination campaign, more than 16 years of age received two doses of vaccine regimen 21 days apart
The new crown pneumonia after researchers recently vaccinated BNT162b2 mRNA vaccine has been systematically studied the risk of myocarditis myocarditis risk after researchers recently vaccinated BNT162b2 mRNA vaccine has been systematically studied
The researchers reviewed the data of all myocarditis cases in Israel from December 20, 2020 to May 31, 2021, examined the incidence of myocarditis after the first and second vaccination (21 days apart), and calculated after the first administration The incidence of myocarditis observed at 21 days and 30 days after the second dose was compared with historical data over the same period and data from the unvaccinated population
During the study period, 304 patients with myocarditis symptoms were reported, of which 21 were diagnosed with other diseases.
Diagnosis Compared with the expected incidence based on historical data, the standardized incidence of myocarditis after vaccination in 16-19-year-old males was 5.
Myocarditis after BNT162b2 vaccination
Myocarditis event after BNT162b2 vaccination BNT162b2 myocarditis event after vaccinationThe study found that vaccination with BNT162b2 vaccine has a lower absolute risk of adverse events of myocarditis, but the risk of myocarditis after vaccination in young men is worthy of attention.
Vaccination of BNT162b2 vaccine, the absolute risk of adverse events of myocarditis is low, but the risk of myocarditis after vaccination in young men is worthy of attention.
Original source:
Dror Mevorach et al.
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.
Leave a message here